M4MM

Cronos Group Inc Reports Q2 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...

Cresco Labs Reports Q2 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...

MariMed Reports Q2 2025 Financial Results

NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...

Verano Holdings Reports 2023 Financial Outcomes

LOS ANGELES- Verano Holdings Corp a  player in the multi-state cannabis industry, has disclosed its financial performance for the fourth quarter and the entirety of 2023, demonstrating resilience and strategic growth despite facing industry-wide challenges. ...

Wyoming Enacts Ban on Delta-8 THC

LOS ANGELES- Wyoming's hemp-derived cannabinoid market faces significant disruption following the recent enactment of a law banning delta-8 THC products. Republican Governor Mark Gordon's decision to sign Senate File 32 into law marks a decisive ...

Subscribe To Our Newsletter